BIOMAT Database Logo BIOMAT Database Logo

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. 1995

H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Department of Cardiovascular Research, Genentech, Inc., South San Francisco, California 94080, USA.

Bactericidal/permeability-increasing protein (BPI) is a neutrophil primary granule protein that inhibits effects of LPS in vitro. The current study examined the effects of BPI on hemodynamics, mortality, and circulating endotoxin and cytokines in conscious rats with endotoxic shock. Catheters were implanted into the right femoral artery and vein. 1 d later, human recombinant BPI (10 mg/kg) or vehicle was intravenously injected immediately, 30 min, or 2 h after intravenous injection of LPS (7.5 mg/kg). Mean arterial pressure (MAP) and heart rate were monitored and blood was collected before and after injection. BPI given immediately or 30 min after LPS prevented the LPS-induced reduction in MAP at 4-8 h and markedly reduced mortality. BPI given 2 h after LPS injection had no protective effect. BPI treated immediately after LPS reduced the circulating levels of endotoxin and IL-6 but increased the circulating levels of TNF. We propose that BPI exerts its protective effect through a TNF-independent mechanism, by inhibiting endotoxin-stimulated production of IL-6.

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
[Protective effects of bactericidal/permeability-increasing protein on the vital organ function after endotoxic shock in rats].
February 1999, Zhonghua wai ke za zhi [Chinese journal of surgery],
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock.
September 2016, Scientific reports,
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Bactericidal/permeability-increasing protein ameliorates hypercoagulability after hemorrhagic shock.
August 1997, Thrombosis research,
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Protective effects of a recombinant N-terminal fragment of bactericidal/permeability increasing protein on endotoxic shock in conscious rabbits.
November 1994, Shock (Augusta, Ga.),
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
[Attempted protection against experimental endotoxic shock].
January 1975, Giornale di batteriologia, virologia ed immunologia,
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.
January 2007, Infection and immunity,
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and gram-negative bacteria.
June 2008, Journal of immunology (Baltimore, Md. : 1950),
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.
April 1996, QJM : monthly journal of the Association of Physicians,
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein.
January 2004, Blood,
H Jin, and R Yang, and S Marsters, and A Ashkenazi, and S Bunting, and M N Marra, and R W Scott, and J B Baker
Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.
November 2004, Inflammatory bowel diseases,
Copied contents to your clipboard!